Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Selection of G. parasuis field isolates used for infection challenge

From: TbpB-based oral mucosal vaccine provides heterologous protection against Glässer’s disease caused by different serovars of Spanish field isolates of Glaesserella parasuis

Isolate IDa

Pathologic process

Serovar

TbpBb cluster

Gp-12

Systemic

5

III

Gp-39

Respiratory

4

I

Gp-46

Systemic

1

I

Gp-52

Respiratory

7

III

  1. IDa: Identification code of the isolate; TbpBb: Transferrin-binding